RACHEL WILKINSON: Open Payments
NPI 1457483810 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 65 payments from 13 companies in 2025. Trend: 2023 $893 · 2024 $900 · 2025 $1,225
Food & beverage: $1,225
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $249 |
| Novartis Pharmaceuticals Corporation | 9 | $166 |
| Boston Scientific Corporation | 7 | $166 |
| Amgen Inc. | 7 | $117 |
| E.R. Squibb & Sons, L.L.C. | 6 | $115 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $76 |
| Alnylam Pharmaceuticals Inc. | 4 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| BridgeBio Pharma, Inc. | 2 | $37 |
Products named: LEQVIO, WATCHMAN FLX, VYNDAQEL, ELIQUIS, REPATHA, Kerendia, CAMZYOS, AMVUTTRA.
Industry payments across AL — which companies pay providers there.
